Point72 Asset Management, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share (SNDX)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share
Symbol
SNDX
Shares outstanding
85.5M shares
Disclosed Ownership
2.31M shares
Ownership
2.7%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 17:39:50 UTC
Date of event
30 Jun 2025
Previous filing
22 Jan 2025
Next filing
18 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 2.7% 2.31M 0 2.31M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 2.7% 2.31M 0 2.31M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 2.7% 2.31M 0 2.31M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person